e-Drug3D

1077

CYCLOSERINE


INN
CYCLOSERINE

cas 68-41-7
CLASS

ANTIINFECTIVES
TUBERCULOSTATIC
ANTIFUNGAL
ANTIBIOTIC
ANTIBACTERIAL
ANTIMETABOLITES
PEPTIDOGLYCAN BIOSYNTHESIS INHIBITOR
NMDA PARTIAL AGONIST

ROUTE (list)

ORAL

NATURAL MOLECULE (link)

ATC code

J04AB01

PK parameters

Tmax 6 HOUR
t1/2 12 HOUR

Solubility

SOLUBLE IN WATER


Target

TARGET NMDA RECEPTOR
D-ALANINE-D-ALANINE LIGASE
ALANINE RACEMASE

PDB
1PB9 (CRYSTAL STRUCTURE OF THE NR1 LIGAND BINDING CORE IN COMPLEX WITH D-CYCLOSERINE AT 1.60 ANGSTROMS RESOLUTION)

Ligand code = 4AX (link to the list of PDB complexes)

Download experimental 3D coordinates of 4AX with added hydrogens

DrugCentral

ligase UNIPROT P9WP31 ddl

Alanine racemase UNIPROT P9WQA9 alr

Download SDF file 4-amino-1,2-oxazolidin-3-one

Formula:
C3H6N2O2

Calculated chemical properties:

MW 102.10
NB_atoms 7
XLogP -1.62
PSA 70.372
NB_HD 3
NB_HA 4
fsp3 0.67
Lipinski(0=no;1=yes) 1

FDA
NDA 060593 (pdf not found) INN (CYCLOSERINE) SEROMYCIN (SANALUZ) APPROVAL= AP YEAR= 1964

Other links:

PubChem
ChemicalProbes

U.S. repository of Clinical Trials

VigiAccess
SIDER side effects

ChemSynthesis
Patent@SureChEMBL